Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -31.66% is 54% above its 5-year average of -68.50%, around the middle of its 5-year range (-126.06%–21.23%).
50.80% below its 12-month average of -20.99%.
Reported quarterly profit margin; no daily interpolation. Q3 FY2026 (2026-06-30): -29.61%.
NET PROFIT MARGIN
-31.66%
NET PROFIT MARGIN AVG TTM
-20.99%
NET PROFIT MARGIN AVG 3Y
-52.49%
NET PROFIT MARGIN AVG 5Y
-68.50%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-50.80%
CURRENT VS 3Y AVG
+39.68%
CURRENT VS 5Y AVG
+53.78%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-12076.92%
vs the sector median at left
Twist Bioscience Corporation
Market Cap
$10.50B
Net Profit Margin
-31.66%
TTM Avg
-20.99%
3Y Avg
-52.49%
5Y Avg
-68.50%
Market Cap
$10.68B
Net Profit Margin
8.42%
TTM Avg
7.89%
3Y Avg
6.46%
5Y Avg
6.98%
Market Cap
$10.26B
Net Profit Margin
17.03%
TTM Avg
11.20%
3Y Avg
12.20%
5Y Avg
12.89%
Market Cap
$10.26B
Net Profit Margin
-0.02%
TTM Avg
1.97%
3Y Avg
2.41%
5Y Avg
2.58%
Market Cap
$10.26B
Net Profit Margin
-12.18%
TTM Avg
-18.34%
3Y Avg
-27.51%
5Y Avg
-50.59%
Market Cap
$10.84B
Net Profit Margin
2.14%
TTM Avg
12.89%
3Y Avg
9.87%
5Y Avg
13.65%
Market Cap
$10.15B
Net Profit Margin
-598.56%
TTM Avg
-1557.47%
3Y Avg
-67611.49%
5Y Avg
-57374.18%
Market Cap
$10.14B
Net Profit Margin
9.99%
TTM Avg
10.36%
3Y Avg
10.48%
5Y Avg
22.21%
Market Cap
$11.00B
Net Profit Margin
13.46%
TTM Avg
9.62%
3Y Avg
9.77%
5Y Avg
24.94%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Twist Bioscience Corporation (TWST) | $10.50B | -31.66% | -20.99% | -52.49% | -68.50% |
| Universal Health Services, Inc. (UHS)vs › | $10.68B | 8.42% | 7.89% | 6.46% | 6.98% |
| Globus Medical, Inc. (GMED)vs › | $10.26B | 17.03% | 11.20% | 12.20% | 12.89% |
| Molina Healthcare, Inc. (MOH)vs › | $10.26B | -0.02% | 1.97% | 2.41% | 2.58% |
| 10x Genomics, Inc. (TXG)vs › | $10.26B | -12.18% | -18.34% | -27.51% | -50.59% |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.84B | 2.14% | 12.89% | 9.87% | 13.65% |
| ImmunityBio, Inc. (IBRX)vs › | $10.15B | -598.56% | -1557.47% | -67611.49% | -57374.18% |
| Align Technology, Inc. (ALGN)vs › | $10.14B | 9.99% | 10.36% | 10.48% | 22.21% |
| The Cooper Companies, Inc. (COO)vs › | $11.00B | 13.46% | 9.62% | 9.77% | 24.94% |
| The Ensign Group, Inc. (ENSG)vs › | $10.00B | 6.90% | 6.89% | 6.71% | 6.89% |
Operating Margin
-31.9%
Net Profit Margin
-31.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -29.61% |
| 2026-03-31 | -39.76% |
| 2025-12-31 | -29.42% |
| 2025-09-30 | -27.41% |
| 2025-06-30 | 21.23% |
| 2025-03-31 | -42.38% |
| 2024-12-31 | -35.61% |
| 2024-09-30 | -40.91% |
| 2024-06-30 | -105.04% |
| 2024-03-31 | -60.41% |
| 2023-12-31 | -60.15% |
| 2023-09-30 | -69.08% |
| 2023-06-30 | -90.05% |
| 2023-03-31 | -98.30% |
| 2022-12-31 | -77.10% |
| 2022-09-30 | -89.20% |
| 2022-06-30 | -107.85% |
| 2022-03-31 | -126.06% |
| 2021-12-31 | -108.44% |
| 2021-09-30 | -108.67% |
| 2021-06-30 | -114.33% |
| 2021-03-31 | -121.52% |
| 2020-12-31 | -116.83% |
| 2020-09-30 | -74.98% |
| 2020-06-30 | -133.01% |
| 2020-03-31 | -164.63% |
| 2019-12-31 | -324.16% |
| 2019-09-30 | -198.15% |
| 2019-06-30 | -205.26% |
| 2019-03-31 | -191.29% |
| 2018-12-31 | -197.00% |
| 2018-09-30 | -235.54% |
| 2018-06-30 | -269.44% |
| 2018-03-31 | -273.65% |
| 2017-12-31 | -392.70% |
| 2017-09-30 | -490.74% |
| 2017-06-30 | -450.79% |
